Related Experiment Video
Updated: Sep 7, 2025

Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
Published on: May 10, 2021
DKK3/CKAP4 axis is associated with advanced stage and poorer prognosis in oral cancer
Naoki Katase1, Kodai Kudo1,2, Kazuhiro Ogawa1,2
1Department of Oral Pathology, Institute of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Objective:
We previously reported that dickkopf WNT signaling inhibitor 3 (DKK3) would modulate malignant potential of oral squamous cell carcinoma (OSCC) via activating Akt. Recently, cytoskeleton associated protein 4 (CKAP4) functions as receptor of DKK3, which activates Akt in esophageal squamous cell carcinoma, but its expression and function in OSCC were unclear.
Methods:
We studied DKK3 and CKAP4 protein expression in OSCC tissue and investigated the correlation between protein expression and clinical data. We also investigated whether antibodies (Ab) for DKK3 or CKAP4 could suppress malignant potential of the cancer cells.
Results:
DKK3/CKAP4 protein expression was observed in majority of OSCC cases and was associated with significantly higher T-stage and TNM stage. Multivariate analysis revealed that DKK3 and CKAP4 were independent prognostic biomarkers for overall survival (OS) and disease-free survival (DFS), respectively. Survival analyses revealed that DKK3-positive cases and CKAP4-positive cases showed significantly shorter OS and DFS, respectively, and that DKK3/CKAP4 double-negative cases showed significantly favorable prognosis. Both anti-DKK3Ab and anti-CKAP4Ab could suppress cancer cell proliferation, migration, and invasion.
Conclusion:
DKK3/CKAP4 axis is thought to be important in OSCC, and it would be a promising therapeutic target.
Insights
The dickkopf WNT signaling inhibitor 3 (DKK3) and cytoskeleton associated protein 4 (CKAP4) axis promotes oral squamous cell carcinoma (OSCC) progression. Targeting this DKK3/CKAP4 pathway with antibodies offers a potential therapeutic strategy for OSCC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Dickkopf WNT signaling inhibitor 3 (DKK3) modulates oral squamous cell carcinoma (OSCC) malignancy by activating Akt.
- Cytoskeleton associated protein 4 (CKAP4) acts as a DKK3 receptor, activating Akt in esophageal cancer, but its role in OSCC was unknown.
Purpose of the Study:
- To investigate the expression and clinical significance of DKK3 and CKAP4 in OSCC.
- To evaluate the potential of anti-DKK3 and anti-CKAP4 antibodies as therapeutic agents against OSCC.
Main Methods:
- DKK3 and CKAP4 protein expression was analyzed in OSCC tissues.
- Correlation between protein expression and clinical data was assessed.
- The effect of anti-DKK3 and anti-CKAP4 antibodies on cancer cell behavior was examined.
Main Results:
- DKK3 and CKAP4 were frequently expressed in OSCC and correlated with advanced T-stage and TNM stage.
- DKK3 and CKAP4 served as independent prognostic biomarkers for overall survival and disease-free survival, respectively.
- DKK3/CKAP4 double-negative status indicated a favorable prognosis, while antibodies against DKK3/CKAP4 inhibited cancer cell proliferation, migration, and invasion.
Conclusions:
- The DKK3/CKAP4 axis plays a crucial role in OSCC progression.
- Targeting the DKK3/CKAP4 pathway presents a promising therapeutic strategy for OSCC treatment.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

